MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) announced its financial results for the full year and three months ended December 31, 2024.
Fourth quarter earnings
MediPharm reported that its revenue increased 32% to C$12 million versus last year’s fourth quarter revenue of C$9.1 million. International revenue accounted for 54% of the…
Please login to read all 545 words.
